Borm, Carlijn D. J. M.
Werkmann, Mario
de Graaf, Debbie
Visser, Femke
Hofer, Arno
Peball, Marina
Smilowska, Katarzyna
Putz, Diana
Seppi, Klaus
Poewe, Werner
Hoyng, Carel
Bloem, Bastiaan R.
Theelen, Thomas
de Vries, Nienke M.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Undetected ophthalmological disorders in Parkinson’s disease
https://doi.org/10.1007/s00415-022-11014-0
Funding for this research was provided by:
Stichting ParkinsonFonds (36000)
Article History
Received: 18 December 2021
Revised: 1 February 2022
Accepted: 4 February 2022
First Online: 9 March 2022
Declarations
:
: Drs. Borm: reports no disclosures. Drs. Werkmann: reports no disclosures. Drs. De Graaf: reports no disclosures. Drs. Visser: reports no disclosures. A. Hofer: reports no disclosures. Drs. Peball: is an employee of the Medical University Innsbruck and reports travel grants from the International Parkinson’s disease and Movement Disorder Society and the Austrian Parkinson’s Disease Society. Dr. Smilowska: reports research fellowship from European Academy of Neurology. Dr. Putz: reports no disclosures. Prof. Seppi: reports personal fees from Teva, UCB, Lundbeck, AOP Orphan Pharmaceuticals AG, Roche, Grünenthal and Abbvie, honoraria from the International Parkinson and Movement Disorders Society, research grants from FWF Austrian Science Fund, Michael J. Fox Foundation, and International Parkinson and Movement Disorder Society, outside the submitted work. Prof. Poewe: reports no disclosures. Prof. Hoyng: reports no disclosures. Prof. Bloem: Dr Bloem reports grants from the Michael J. Fox Foundation, ZonMw, Stichting Parkinson Nederland, Parkinson Vereniging, Hersenstichting Nederland, Parkinson’s Foundation, Verily Life Sciences, Horizon 2020, and Topsector Life Sciences and Health; grants and personal fees from UCB; and personal fees from Abbvie, Bial, and Zambon, outside the submitted work. Dr. Theelen: reports no disclosures. Dr. De Vries: reports grants from ZonMw and The Michael J Fox Foundation. No other disclosures were reported.
: The Medical Ethics Committee Arnhem-Nijmegen (NL58535.091.16) and Innsbruck (AN2016–0181) approved the study.